Thursday May 08 2014 Abstracts selected for presentation will be available online by April 15, 2014 |
|||
PLENARY SESSIONS | |||
08:00-09:00 | PL07 | Fetal Neurology: An emerging subspeciality? | Adré Jacques du Plessis, USA |
09:00-10:00 | PL08 | Brain injury in the newborn - Importance of the everyday (Prichard Award Lecture) | Steven Paul Miller, Canada |
10:00-10:30 | COFFEE & POSTER VIEWING / TRADE EXHIBITION | ||
CONCURRENT SYMPOSIA | |||
CATARATAS I | |||
10:30-12:30 | S13 | Frontiers in Neuroprotection of the neonatal brain | |
Chair: Rand Askalan (Canada) | |||
Neuroprotection of the neonatal brain | Rand Askalan, Canada | ||
Lessons learned from the adult brain on the translation of preconditioning against ischemic injury | Mary Stenzel-Poore, USA | ||
Hypothermia and potential strategies to maximize its utility in protecting the developing ischemic brain | Michael Johnston, USA | ||
Promising strategies of neuroprotection for the developing brain | Jerome Yager | ||
CATARATAS II | |||
10:30-12:30 | S14 | Acute Leukoencephalopathies in Children | |
Chair: Andrew Kornberg (Australia) ; Silva Tenembaum (Argentina) | |||
Acute event with bithalamic involvement | Andrew Kornberg, Australia | ||
Acute leukoencephalopathy and CNS vasculopathy | Silvia Tenembaum, Argentina | ||
Acute leukoencephalopathy and Pediatric Multiple Sclerosis | Lauren Krupp, USA | ||
Acute leukoencephalopathy and Neuromyelitis Optica | Daniela Pohl, Canada | ||
IGUAÇU I | |||
10:30-12:30 | S15 | NeuroInflammation | |
Chair: Russel Dale (Australia) | |||
Overview of CNS inflammation: mechanisms and interventions | Ming Lim, UK | ||
Neuroinflammation and Neuroimmune Interaction. Inflammatory component in the pathogenesis of Autism Spectrum Disorders | Andrew Zimmerman, USA | ||
The Role of Neuroinflammation in the Encephalopathy of Prematurity | Bobbi Fleiss, UK | ||
Inflammation in the Neuronal Ceroid Lipofusinoses (NCL) | Jonathan Mink, USA | ||
IGUAÇU II | |||
10:30-12:30 | S16 | Update on Neuromuscular Disorders | |
Chair: Rosalin Quinlivan (UK) | |||
Hazardous Neuromuscular disorders - The malignant hyperthermia story and RYR1 mutations - Implications to practics | Heinz Jungbluth, UK | ||
Hazardous Neuromuscular disorders - More metabolic / hazardous neuromuscular diseases ie rhabdomyolysis | Rosalin Quinlivan, UK | ||
Latest in therapies for key neuromuscular disorders | Carsten Bonneman, USA | ||
Standards of care for SMA and DMD | Jo Wilmshurst, South Africa | ||
Neuromuscular and neurodevelopmental disorders associated with defective autophagy | Heinz Jungbluth, UK | ||
12:30-14:00 | LUNCH / TRADE EXHIBITION / LUNCH TIME MEETINGS | ||
13:00-14:00 | ACNA EXECUTIVE BOARD MEETING (CLOSED SESSION) | ||
PLATFORM SESSIONS | |||
IGUAÇU 1 | |||
14:00-17:00 | NEONATAL & FETAL NEUROLOGY | ||
Chair: TBA | |||
0200 - 0215 PM | FP100: Rotavirus infection can cause seizures accompanied by diffuse cerebral white matter injury in full-term newborns | Kyung Yeon Lee, Korea.Republic | |
0215 - 0230 PM | FP101: Burden of neurologic disease in a peruvian neonatal intensive care unit | Pilar Medina, Peru | |
0230 - 0245 PM | FP102: Experience with induced hypothermia at a tertiary hospital in a resource limited setting: preliminary results | Firdose Nakwa, South Africa | |
0245 - 0300 PM | FP103: Fetal ventriculomegaly investigations and outcomes - 5 year experience | Prakash Satodia, UK | |
0300 - 0315 PM | FP104: Fetal MR Imaging. What is the outcome? | Prakash Satodia, UK | |
0315 - 0330 PM | FP105: Emergence and evolution of neurological deficits following acute neonatal arterial ischemic stroke | Mahendranath Moharir, Canada | |
0330 - 0345 PM | FP106: Levetiracetam as a treatment of neonatal seizures | Hyoung Won Choi, USA | |
0345 - 0400 PM | FP107: A Neonatal Seizure Blinded Treatment Trial | Richard Haas, USA | |
0400- 0415 PM | FP108: Toward Prenatal diagnosis of Prader Willi Syndrome | Varda Gross-tsur, Israel | |
0415 - 0430 PM | FP109: The neurological development of newborns at high risk through outpatient services by multidisciplinary team | Alexandra Serafim, Brazil | |
0430 - 0445 PM | FP110: Altered expression of non-neuronal cells in normal and Down syndrome developing brain | Takeshi Kanaumi, Japan | |
0445- 0500 PM | FP111: Transcription Regulation of Thyroxin Protective Effect on White Matter Injury | Hung Pi-lien, Taiwan | |
IGUAÇU II | |||
14:00-17:00 | NEUROONCOLOGY / NEURORADIOLOGY | ||
Chair: TBA | |||
0200 - 0215 PM | FP112: Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): EXIST-1 long-term efficacy and safety results | David Franz, USA | |
0215 - 0230 PM | FP113: Safety of everolimus in patients | Sergiusz Jozwiak, Poland | |
0230 - 0245 PM | FP114: Posterior fossa syndrome and mutism in children after cerebellar tumor surgery | Maria Buompadre, Argentina | |
0245 - 0300 PM | FP115: Gliomatosis Ceribri in childhood - case report | Rudimar dos Santos Riesgo, Brazil | |
0300 - 0315 PM | FP116: Serum alpha-tocopherol, vitamin B12 and folate levels in Childhood ALL (Acute Lymphoblastic Leukemia) survivors with and without neuropathy | Puneet Jain, India | |
0315 - 0330 PM | FP117: Spectrum of Neurological Complications in Childhood Malignancies-A Study from India | Lokesh Lingappa, India | |
0330 - 0345 PM | FP118: White Matter Microstructural Integrity in Syndromic and Idiopathic Autism | Fiona Baumer, USA | |
0345 - 0400 PM | FP119: Microstructural abnormalities of the supratentorial white matter tracts on brain MRI in X-Linked MCT8 deficiency: Implications for earlier diagnosis and treatments | Maia Gisele Matheus, USA | |
0400- 0415 PM | FP120: Atypical Case of a HSV-1 Meningoencephalitis (HSE) Involving Corpus Striatum | Nezir Özgün, Turkey | |
0415 - 0430 PM | FP121: Novel findings with susceptibility weighted imaging in acute-stage paediatric convulsive disorders | Hiroki Iwasaki, Australia | |
0430 - 0445 PM | FP122: Conventional magnetic resonance imaging in the differentiation between high and low-grade brain tumours in paediatric patients | Luciana Porto, Germany | |
0445- 0500 PM | FP123: valuation of the nerve conduction studies and autonomic functions in patients with agenesis of corpus callosum | Erhan Bayram, Turkey | |
CATARATAS I | |||
14:00-17:15 | METABOLIC DISORDERS | ||
Chair: TBA | |||
0200 - 0215 PM | FP124: Insights into therapeutic mechanisms of L-arginine therapy in MELAS syndrome using exercise testing with cycle ergometry and 31P-MRS of muscle | Lance Rodan, Canada | |
0215 - 0230 PM | FP125: Methylmalonic acidemia: diagnosis and long-term outcome | Juliana Pinheiro, Brazil | |
0230 - 0245 PM | FP126: Subacute combined sclerosis of the spinal cord and necrotizing enterocolitis after ileal resection: a forgotten link | Gustavo Holanda, Brazil | |
0245 - 0300 PM | FP127: Coenzyme q10 deficiency: clinical and biochemical characterization | Juliana Arita, Brazil | |
0300 - 0315 PM | FP128: MELAS syndrome is associated with impaired cerebrovascular reactivity and cerebral hyperperfusion in between stroke-like episodes | Lance Rodan, Canada | |
0315 - 0330 PM | FP129: White matter disorders in a series of 150 patients with metabolic disease | Mónica Troncoso, Chile | |
0330 - 0345 PM | FP130: Mitochondrial dna disease: clinical spectrum from the genotype to the phenotype | Paola Santander, Chile | |
0345 - 0400 PM | FP131: Glutaric aciduria type i (ga1), clinical caracterization and genetic study of 11 chilean children. | Mónica Troncoso, Chile | |
0400- 0415 PM | FP132: Congenital metabolism diseases of neurotransmitters in pediatric neurology: clinical description and neurological tracing of a group of patients. | Mónica Troncoso, Chile | |
0415 - 0430 PM | FP133: Clinical profile of children with biotinidase deficiency and response to oral biotin therapy: Experience from a developing country | Arushi Saini, India | |
0430 - 0445 PM | FP134: Abnormal Pupillary Light Reflex with Chromatic Pupillometry in Gaucher disease; relation to phenotype and therapeutic response with chaperone therapy | Aya Narita, Japan | |
0445- 0500 PM | FP135: 2-HydroxyGlutaric Aciduria in Saudi Arabia | Majed Dasouki, Saudi Arabia | |
0500-0515 PM | FP136: Mitochondrial Molecular Genetic Mutations found in a South African population 1992-2012 | Gillian Riordan, South Africa | |
CATARATAS II | |||
14:00-17:00 | MUSCLE & NERVE | ||
Chair: TBA | |||
0200 - 0215 PM | FP137: Skin biopsy in childhood muscular dystrophies; is it the way ahead for diagnosis, monitoring and prognosis? | Vrajesh Udani, India | |
0215 - 0230 PM | FP138: Clinical aspects of a treatable form of childhood peripheral neuropathy due to riboflavin transporter deficiency caused by mutations of the SLC52A2 gene | Robert Ouvrier, Australia | |
0230 - 0245 PM | FP139: Enterovirus 71 associated lower motor neuron disease in infants and children | Tejaswi Kandula, Australia | |
0245 - 0300 PM | FP140: Bone health in Duchenne muscular dystrophy: natural history, pathogenesis and treatment | Hugo Sampaio, Australia | |
0300 - 0315 PM | FP141: Spinal Muscular Atrophy life span | Alexandra Prufer de Q. C. Araujo, Brazil | |
0315 - 0330 PM | FP142: Peripheral nerve ultrasound in paediatric Charcot-Marie-Tooth disease Type 1A | Eppie Yiu, Australia | |
0330 - 0345 PM | FP143: Schwartz Jampel Syndrome: Two cases report | Joao Tussolini, Brazil | |
0345 - 0400 PM | FP144: Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy | Li Jiang, China | |
0400- 0415 PM | FP145: Prevalence of electrophysiologically defined peripheral neuropathy in children with chronic kidney disease stage IV and V: a cross sectional study | Sangeetha Yoganathan, India | |
0415 - 0430 PM | FP146: Phenotype - genotype analysis of Chinese patients with early-onset LMNA-related muscular dystrophy | Hui Xiong, China | |
0430 - 0445 PM | FP147: Sibling-pair with Mitofusin 2 mutation | Siddharth Jain, UK | |
0445- 0500 PM | FP148: Reliability of the ek scale versus hand grip dynamometer testing in non-ambulant duchenne muscular dystrophy patients | Stacey Tay, Singapore |
Inflammation in the Neuronal Ceroid Lipofusinoses (NCL)